Roivant Sciences Ltd. bought IMVT
December 12, 2025 · Form 4 insider transaction
Roivant Sciences Ltd. bought 16,666,666 shares of Immunovant, Inc. at $21.00 per share, a transaction worth $350.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,666,666
Price
$21.00
Total value
$350.00M
InsiderRoivant Sciences Ltd.
RoleDirector, 10% owner
CompanyImmunovant, Inc. (IMVT)
SecurityCommon Stock, $0.0001 par value per share
Transaction codeP: Open-market purchase
Transaction dateDecember 12, 2025
Filing dateDecember 12, 2025
Shares owned after113,317,007
OwnershipDirect
10b5-1 planNo
AmendedNo